Garnier M, Boujrad N, Ogwuegbu S O, Hudson J R, Papadopoulos V
Department of Cell Biology, Georgetown University Medical Center, Washington, D.C. 20007.
J Biol Chem. 1994 Sep 2;269(35):22105-12.
The polypeptide diazepam binding inhibitor (DBI) and drug ligands for the mitochondrial peripheral-type benzodiazepine receptor (PBR) have been shown to regulate cholesterol transport, the rate-determining step in steroidogenesis, in hormone-responsive steroidogenic cells including the MA-10 Leydig tumor cells. The present study was designed to characterize the role of DBI and PBR in the R2C rat Leydig tumor constitutive steroid-producing cell model. Both DBI and PBR were present in R2C cells. R2C cell treatment with a cholesterol-linked phosphorothioate oligodeoxynucleotide antisense to DBI, but not sense, resulted in the reduction of DBI levels and a concomitant dramatic decrease of the amount of progesterone produced. These observations strongly suggested that DBI was important in maintaining constitutive steroidogenesis in R2C cells. Radioligand binding assays revealed the presence of a single class of PBR binding sites with an affinity 10 times higher (Kd approximately 0.5 nM) than that displayed by the MA-10 PBR (Kd approximately 5 nM). Photolabeling of R2C and MA-10 cell mitochondria with the photoactivatable PBR ligand [3H]1-(2-fluoro-5-nitrophenyl)-N-methyl-N-(1-methyl-propyl)-3- isoquinolinecarboxamide showed that the M(r) 18,000 PBR protein was specifically labeled. This indicates that the R2C cells express a PBR protein which has properties similar to the MA-10 PBR. Chemical crosslinking studies of purified metabolically radiolabeled DBI to mitochondria provided direct evidence that DBI specifically binds to the M(r) 18,000 PBR protein. Moreover, DBI and a PBR synthetic ligand were able to increase steroid production in isolated R2C cell mitochondria which express the 5 nM affinity receptor. However, mitochondrial PBR binding was increased by 6-fold upon addition of the post-mitochondrial fraction, suggesting that a cytosolic factor modulates the binding properties of PBR in R2C cells and is responsible for the 0.5 nM affinity receptor seen in intact cells. In conclusion, these data demonstrate that DBI plays a key role in maintaining R2C constitutive steroidogenesis by binding to the mitochondrial higher affinity PBR which promotes a continuous supply of cholesterol to the inner mitochondrial side chain cleavage cytochrome P450.
多肽地西泮结合抑制剂(DBI)和线粒体外周型苯二氮䓬受体(PBR)的药物配体已被证明可调节胆固醇转运,这是类固醇生成中的限速步骤,在包括MA-10睾丸间质细胞瘤细胞在内的激素反应性类固醇生成细胞中。本研究旨在表征DBI和PBR在R2C大鼠睾丸间质瘤组成型类固醇生成细胞模型中的作用。DBI和PBR均存在于R2C细胞中。用与DBI反义的胆固醇连接的硫代磷酸酯寡脱氧核苷酸处理R2C细胞,而不是正义链,导致DBI水平降低,同时孕酮产生量显著减少。这些观察结果强烈表明DBI在维持R2C细胞中的组成型类固醇生成中很重要。放射性配体结合分析显示存在一类单一的PBR结合位点,其亲和力比MA-10 PBR(Kd约为5 nM)高10倍(Kd约为0.5 nM)。用可光活化的PBR配体[3H]1-(2-氟-5-硝基苯基)-N-甲基-N-(1-甲基丙基)-3-异喹啉甲酰胺对R2C和MA-10细胞线粒体进行光标记,结果表明分子量为18,000的PBR蛋白被特异性标记。这表明R2C细胞表达一种与MA-10 PBR具有相似特性的PBR蛋白。对纯化的经代谢放射性标记的DBI与线粒体进行化学交联研究,提供了DBI特异性结合分子量为18,000的PBR蛋白的直接证据。此外,DBI和一种PBR合成配体能够增加表达5 nM亲和力受体的分离的R2C细胞线粒体中的类固醇生成。然而,加入线粒体后组分后,线粒体PBR结合增加了6倍,这表明一种胞质因子调节R2C细胞中PBR的结合特性,并负责在完整细胞中看到的0.5 nM亲和力受体。总之,这些数据表明DBI通过与线粒体高亲和力PBR结合在维持R2C组成型类固醇生成中起关键作用,该PBR促进胆固醇持续供应到线粒体内侧链裂解细胞色素P450。